Apogee Therapeutics, Inc. Retained Earnings
Apogee Therapeutics, Inc. (APGE) had Retained Earnings of -$721.72 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-10
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$721.72M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$635.87M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$561.76M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$492.37M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$721.72M 10-Q · filed 2026-08-10 |
| 2026-03-31 | -$635.87M 10-Q · filed 2026-05-11 |
| 2025-12-31 | -$561.76M 10-Q · filed 2026-08-10 |
| 2025-09-30 | -$492.37M 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$427.35M 10-Q · filed 2025-08-11 |
| 2025-03-31 | -$361.25M 10-Q · filed 2025-05-12 |
| 2024-12-31 | -$305.92M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$238.70M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$189.68M 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$155.86M 10-Q · filed 2024-05-13 |
| 2023-12-31 | -$123.77M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$92.03M 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$71.19M 10-Q · filed 2023-08-28 |
| 2022-12-31 | -$39.78M 10-K · filed 2024-03-05 |